title: Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma.
authors.affiliation: Havener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University, Wexner Medical Center, Columbus.
authors.forename: Dimosthenis
authors.initials: D
authors.lastname: Mantopoulos
authors.affiliation: Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Wexner Medical Center, Columbus.
authors.forename: Kari L
authors.initials: KL
authors.lastname: Kendra
authors.affiliation: Havener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University, Wexner Medical Center, Columbus.
authors.forename: Alan D
authors.initials: AD
authors.lastname: Letson
authors.affiliation: Havener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University, Wexner Medical Center, Columbus.
authors.forename: Colleen M
authors.initials: CM
authors.lastname: Cebulla
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D015862:Choroid Diseases / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D000074324:Ipilimumab; D008279:Magnetic Resonance Imaging; D008545:Melanoma / Q000188:drug therapy*; D064847:Multimodal Imaging; D012163:Retinal Detachment / Q000139:chemically induced* / Q000175:diagnosis; D012878:Skin Neoplasms / Q000188:drug therapy*; D058471:Subretinal Fluid; D041623:Tomography, Optical Coherence
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab